U.K. questions NBTY acquisition
This article was originally published in The Tan Sheet
The U.K. trade regulator says NBTY's acquisition of natural food and ingredients retailer Julian Graves potentially could hinder competition in the nuts, seeds and dried fruit market, and referred the deal for review to its Competition Commission. Because NBTY owns Holland & Barrett, the leading U.K. health food products retailer, the Office of Fair Trading said March 20 it did not receive "sufficient evidence" that other retailers currently adequately constrain NBTY's influence on competition in this area. NBTY and Julian Graves also overlap in vitamins, minerals and supplements sales, but OFT ruled out competition concerns because Julian Graves "sells only limited quantities." Ronkonkoma, N.Y.-based NBTY, which is acquiring Julian Graves through its NBTY Europe subsidiary for approximately $25 million, said it expects the commission's decision by Sept. 3 (1"The Tan Sheet" Sept. 22, 2008, p. 14)
You may also be interested in...
NBTY increases its influence on competition in the vitamin and dietary supplement ingredient supply market with its acquisition of U.K. natural foods retailer Julian Graves
EU Regulatory Roundup, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.